Join to access to all OVN content. Join for Free
Career Resiliency: How to Survive and Thrive After a Lay Off
medical affairs industry career progression industry layoffs mentorship in medical affairs career building strategies

Career Resiliency: How to Survive and Thrive After a Lay Off


Share This Article


Summary

In this episode, Tom Caravela is joined by Carol Lawlor to discuss her career journey and the challenges faced in the medical affairs industry. Carol shares her personal experiences transitioning into the field, addressing the emotional impact of industry layoffs and offering strategies for job searching with resilience. She provides insightful advice on career progression and highlights emerging roles in medical affairs. The conversation also delves into the importance of mentorship and continuous education for career building. The episode concludes with Carol's reflections on her journey and final thoughts for those navigating the industry.

My guest today is Carol Lawlor, National Director, Field Medical – Northeast at Alkermes, discusses her career resiliency story and how she overcame an unexpected lay off

Carol shares…

๐Ÿ‘‰ Her medical background and industry transition
๐Ÿ‘‰ How she landed in her first industry roll… and what happened next
๐Ÿ‘‰ Advice for others suffering career setbacks
๐Ÿ‘‰ What new areas or opportunities she sees developing
๐Ÿ‘‰ Advice for those looking to build a career in medical affairs

Click for Source
medical affairs industry, career progression, industry layoffs, mentorship in medical affairs, career building strategies

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Promotability: How to Land Your Next Promotion
Partner Avatar Tom Caravela

Promotability: How to Land Your Next Promotion

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Podcast
The ART of Excellence... How to be a Rock Star MSL
Partner Avatar MSL Talk: Tom Caravela, Cathy Andorfer

The ART of Excellence... How to be a Rock Star MSL

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Explore OVN